- Q1 2024 Dynavax Technologies Corp Earnings Call TranscriptMay 08, 2024$11.65 (-0.94%)Earnings
- Q4 2023 Dynavax Technologies Corp Earnings Call TranscriptFeb 22, 2024$12.44 (-0.16%)Earnings
- Dynavax Technologies Corp at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Dynavax Technologies Corp Earnings Call TranscriptNov 02, 2023$14.07 (-0.21%)Earnings
- Dynavax Technologies Corp at H.C. Wainwright & Co LLC 4th Annual Hepatitis B Virus (HBV) Conference (Virtual) TranscriptOct 25, 2023
- Q2 2023 Dynavax Technologies Corp Earnings Call TranscriptAug 03, 2023$13.39 (-1.11%)Earnings
- Dynavax Technologies Corp at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Dynavax Technologies Corp at William Blair Growth Stock Conference TranscriptJun 06, 2023
- Dynavax Technologies Corp at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Q1 2023 Dynavax Technologies Corp Earnings Call TranscriptMay 02, 2023$10.31 (-2.00%)Earnings
- Q4 2022 Dynavax Technologies Corp Earnings Call TranscriptFeb 23, 2023$10.77 (-1.19%)Earnings
- Q3 2022 Dynavax Technologies Corp Earnings Call TranscriptNov 03, 2022$11.17 (-0.89%)Earnings
- Q2 2022 Dynavax Technologies Corp Earnings Call TranscriptAug 04, 2022$14.34 (+1.49%)Earnings
- Q1 2022 Dynavax Technologies Corp Earnings Call TranscriptMay 05, 2022$8.76 (-6.21%)Earnings
- Q4 2021 Dynavax Technologies Corp Earnings Call TranscriptFeb 28, 2022$12.26 (-1.76%)Earnings
- Q3 2021 Dynavax Technologies Corp Earnings Call TranscriptNov 04, 2021$20.76 (-0.86%)Earnings
- Dynavax Technologies Corp at Guggenheim Vaccine and Infectious Disease Conference (Virtual) TranscriptOct 05, 2021
- Dynavax Technologies Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 Dynavax Technologies Corp Earnings Call TranscriptAug 04, 2021$9.88 (+1.44%)Earnings
- Dynavax Technologies Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Dynavax Technologies Corp Annual Shareholders Meeting TranscriptMay 28, 2021
- Q1 2021 Dynavax Technologies Corp Earnings Call TranscriptMay 06, 2021$8.88 (-0.67%)Earnings
- Dynavax Technologies Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Dynavax Technologies Corp Earnings Call TranscriptFeb 25, 2021$8.16 (-13.01%)Earnings
- Q3 2020 Dynavax Technologies Corp Earnings Call TranscriptNov 05, 2020$4.13Earnings
- Q2 2020 Dynavax Technologies Corp Earnings Call TranscriptAug 06, 2020$8.82 (-1.89%)Earnings
- Dynavax Technologies Corp Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 Dynavax Technologies Corp Earnings Call TranscriptMay 07, 2020$4.54 (-2.58%)Earnings
- Dynavax Technologies Corp - To Discuss the Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B - Conference Call TranscriptApr 30, 2020
- Q4 2019 Dynavax Technologies Corp Earnings Call TranscriptMar 11, 2020$3.07 (-18.13%)Earnings
- Q3 2019 Dynavax Technologies Corp Earnings Call TranscriptNov 06, 2019$5.23 (-2.43%)Earnings
- Q2 2019 Dynavax Technologies Corp Earnings Call TranscriptAug 07, 2019$2.99 (+3.82%)Earnings
- Q1 2019 Dynavax Technologies Corp Earnings Call TranscriptMay 08, 2019$6.53 (+0.31%)Earnings
- Q4 2018 Dynavax Technologies Corp Earnings Call TranscriptFeb 26, 2019$10.56 (+1.93%)Earnings
Dynavax Technologies Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Hey, guys, my name is Rob Palermo. I'm part of the biotech research team here at Goldman Sachs. Happy to be here today at the Annual Healthcare Conference with Ryan Spencer, CEO of Dynavax Technologies. We're going to go through presentation today, and then time permitting, we can field some questions if there are any submitted. So how about -- you can take it away, Ryan.
Thanks, Rob. And thank you all for joining us today. I'm Ryan Spencer, Chief Executive Officer of Dynavax Technologies, and I'm excited to share the Dynavax story with you, which, we believe, provides a compelling investment opportunity.
In this corporate overview, we will be making forward-looking statements that are subject to risks and uncertainties as identified on this slide and in our filings with the SEC, which provide details on our business and the associated investment risk, which we encourage you to review.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)